FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/058001 [Registered on: 25/09/2023] Trial Registered Prospectively
Last Modified On: 21/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Clinical study to evaluate the effect of Mulasi powder and Gokshur powder in kidney stone 
Scientific Title of Study   Randomised controlled clinical trial to compare add on effect of musali churna and gokshur churna with gokshur churna in the management of mootrashmari  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Gopal B Kute 
Designation  PG Scholar  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Department of Shalyatantra, Tilak Ayurved Mahavidyalaya Pune.

Pune
MAHARASHTRA
411011
India 
Phone  7558266528  
Fax    
Email  kutegopal.gk@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dhanraj Gaikwad  
Designation  Associate professor , Shalyatantra Department  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Department of shalyatantra, Tilak Ayurved Mahavidyalaya Pune

Pune
MAHARASHTRA
411011
India 
Phone  9422342048  
Fax    
Email  draj.gaikwad@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dhanraj Gaikwad  
Designation  Associate professor , Shalyatantra Department  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Department of shalyatantra, Tilak Ayurved Mahavidyalaya Pune

Pune
MAHARASHTRA
411011
India 
Phone  9422342048  
Fax    
Email  draj.gaikwad@gmail.com  
 
Source of Monetary or Material Support  
Seth Tarachand ramnath charitable ayurvedic hospital pune 
 
Primary Sponsor  
Name  Tilak Ayurved Mahavidyalaya 
Address  Tilak Ayurved Mahavidyalaya,Rasta Peth,Pune 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gopal Kute  Seth Tarachand Ramnath Mahavidyala  Tilak Ayurveda Mahavidyalaya Department of Shalyatantra OPD No.7,Rasta Peth Pune
Pune
MAHARASHTRA 
7558266528

kutegopal.gk@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tilak Ayurved Mahavidyalaya Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N30-N39||Other diseases of the urinary system. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Musali Churna, Reference: Bhaishajya ratnavali 36/18, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -vyushit jala), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Gokshur churna, Reference: Sushrut chikitsasthan adhyay 7, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Sabhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -vyushit jala), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Size of calculus -A known diagnosed case of renal calculus having calculus 4 to 6 mm 
 
ExclusionCriteria 
Details  Patient who are suffering from severe systemic disorders like renal failure, carcinoma
Known case of DM HTN asthma HIV HbsAg
Congenital anomalies of kidney
The pregnant woman  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Sadaha mootra pravrutri
Sarakta mootra pravrutri
Udarshool (Site and intensity)
site of ashmari  
1 month 
 
Secondary Outcome  
Outcome  TimePoints 
Size of stone
Site of stone
No of stone  
3 months  
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   04/10/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Renal stone is a painful condition that affects 1 – 2% of the general population. Kidney stones are aggregates of crystals mixed with a protein matrix that cause obstruction of urine flow in the renal collecting system, ureters, or urethra and result in severe pain, leads to increased urinary bleeding, or local erosion of kidney tissues. The formation of stones in the urinary tract is a common and important problem that must be considered in daily urological practice. With a prevalence of>10% and an expected recurrence rate of 50%, stone disease has an important effect on the health care system. Alternatively, the increased urinary volume could decrease the concentration of inhibitors of stone formation. 
There are various treatment modalities Present for mootrashmari (Renal Calculus) in modern as well are in ayurveda. No work done over effect of Musalichurna in mootrashmari 
Hence this topic is chosen to evaluate the add on effect of musalichurna along with gokshurchurna in management of mootrashmari.
 
Close